1. Home
  2. BTAI
  3. BTAI News

Latest BioXcel Therapeutics Inc. (BTAI) News on September 18, 2025

BioXcel Therapeutics Reports Positive Topline Exploratory Efficacy Data from SERENITY At-Home Pivotal Phase 3 Safety Trial for Agitation Associated with Bipolar Disorders or Schizophrenia

GlobeNewswire

8 days ago

BioXcel Therapeutics Reports Positive Topline Exploratory Efficacy Data from SERENITY At-Home Pivotal Phase 3 Safety Trial for Agitation Associated with Bipolar Disorders or Schizophrenia

MT Newswires

7 months ago

Sector Update: Health Care

MT Newswires

7 months ago

Top Midday Gainers

MT Newswires

7 months ago

Top Midday Gainers

Thomson Reuters StreetEvents

10 months ago

Q3 2024 BioXcel Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents

a year ago

Q2 2024 BioXcel Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents

a year ago

Q1 2024 BioXcel Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents

2 years ago

Q4 2023 BioXcel Therapeutics Inc Earnings Call

Share on Social Networks: